From the Journals

Diabetes, Amyloid-β Interaction Doubles MCI Risk

Managing diabetes may reduce Alzheimer’s risk, as 20-year data reveal synergistic brain changes from diabetes and amyloid-β abnormality.

1

Accelerated brain atrophy and abnormal amyloid-β ratios are significant risk factors for cognitive decline.
2

Type 2 diabetes and low CSF abnormal amyloid-β Aβ42/β40 ratios independently raised the risk of developing MCI.
3

Change-point analyses identified white matter atrophy acceleration beginning at age 62.4 and ventricular enlargement beginning at age 68.
4

The study's limitations include a relatively small sample size, imbalanced sex distribution, and potential imaging variability due to MRI scanner upgrades over time.
5

Shohei Fujita, MD, PhD highlighted the need for more diverse study populations and further investigation into gender and racial differences in neurodegeneration patterns.